<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Demographic and clinical data from 79 patients with CNS infection and enterovirus detection</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2" colspan="2"/>
    <th colspan="2">Children ≤15 years (
     <italic>n</italic> = 51)
    </th>
    <th>Adults &gt; 15 years (
     <italic>n</italic> = 28)
    </th>
    <th rowspan="2">
     <italic>P</italic> value
     <sup>c</sup>
    </th>
   </tr>
   <tr>
    <th>Swab (
     <italic>n</italic> = 41)
    </th>
    <th>CSF (
     <italic>n</italic> = 10)
    </th>
    <th>CSF (
     <italic>n</italic> = 28)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="2">Demographics</td>
    <td>Male (%)</td>
    <td>29 (70.7)</td>
    <td>3 (30)</td>
    <td>18 (64.3)</td>
    <td>0.078</td>
   </tr>
   <tr>
    <td>Age (year) (median; IQR)</td>
    <td>1 (1–3)</td>
    <td>7 (1.8–10)</td>
    <td>20 (17–29.5)</td>
    <td>ND</td>
   </tr>
   <tr>
    <td rowspan="3">Discharge diagnosis</td>
    <td>Encephalitis (%)</td>
    <td>30 (73.2)</td>
    <td>4 (40)</td>
    <td>1 (3.6)</td>
    <td rowspan="3">0.012</td>
   </tr>
   <tr>
    <td>Meningitis (%)</td>
    <td>2 (4.9)</td>
    <td>6 (60)</td>
    <td>26 (92.9)</td>
   </tr>
   <tr>
    <td>Others
     <sup>b</sup>(%)
    </td>
    <td>9 (22)</td>
    <td>0</td>
    <td>1 (3.6)</td>
   </tr>
   <tr>
    <td rowspan="8">Clinical symptoms</td>
    <td>Fever</td>
    <td>40 (97.6)</td>
    <td>9 (90)</td>
    <td>26 (92.9)</td>
    <td>1.0</td>
   </tr>
   <tr>
    <td>Day of illness (med: IQR)</td>
    <td>4 (3–5)</td>
    <td>2 (1.5–3.5)</td>
    <td>2 (1–3)</td>
    <td>0.699</td>
   </tr>
   <tr>
    <td>Duration of hospitalization (med: IQR)</td>
    <td>7 (2.5–12)</td>
    <td>7 (6.5–10.5)</td>
    <td>13 (5–15)</td>
    <td>0.173</td>
   </tr>
   <tr>
    <td>Meningeal signs (%)</td>
    <td>4 (9.8)</td>
    <td>4 (40)</td>
    <td>20 (71.4)</td>
    <td>0.127</td>
   </tr>
   <tr>
    <td>Convulsions (%)</td>
    <td>26 (63.4)</td>
    <td>2 (20)</td>
    <td>0</td>
    <td>0.064</td>
   </tr>
   <tr>
    <td>Focal neurology (%)</td>
    <td>22 (53.7)</td>
    <td>1 (10)</td>
    <td>0</td>
    <td>0.263</td>
   </tr>
   <tr>
    <td>Limb weakness (%)</td>
    <td>22 (53.7)</td>
    <td>1 (10)</td>
    <td>0</td>
    <td>0.263</td>
   </tr>
   <tr>
    <td>GCS &lt; 9 (%)</td>
    <td>25 (61)</td>
    <td>1 (10)</td>
    <td>1 (3.6)</td>
    <td>0.462</td>
   </tr>
   <tr>
    <td rowspan="2">Laboratory tests</td>
    <td rowspan="2">Blood white cell count (per mm3) [med: IQR]</td>
    <td>12,300</td>
    <td>16,800</td>
    <td>9750</td>
    <td rowspan="2">0.010</td>
   </tr>
   <tr>
    <td>(8150–16,225)</td>
    <td>(14875–22,800)</td>
    <td>(7100–11,950)</td>
   </tr>
   <tr>
    <td/>
    <td>Blood neutrophil % (med: IQR)</td>
    <td>53.15 (36–69.8)</td>
    <td>80.8 (73–86.4)</td>
    <td>78.35 (73.1–82.6)</td>
    <td>0.713</td>
   </tr>
   <tr>
    <td/>
    <td>Blood glucose (mmol per litter) [med: IQR]</td>
    <td>5.16 (4.0–7.8)</td>
    <td>5.22 (3.8–6.5)</td>
    <td>6.04 (5.17–7.1)</td>
    <td>0.311</td>
   </tr>
   <tr>
    <td/>
    <td>CSF white cell counts per mm3 (med: IQR)</td>
    <td>5 (1–45.5)</td>
    <td>61 (3.5–172)</td>
    <td>90.5 (27.25–197.5)</td>
    <td>0.926</td>
   </tr>
   <tr>
    <td/>
    <td>CSF neutrophil % (med: IQR)</td>
    <td>20 (11–30)</td>
    <td>63 (37.5–67.5)</td>
    <td>46 (27.8–78.8)</td>
    <td>0.596</td>
   </tr>
   <tr>
    <td/>
    <td>CSF glucose (mmol per litter) [med: IQR]</td>
    <td>3.5 (2.8–4.7)</td>
    <td>3.74 (3.4–4.3)</td>
    <td>3.5 (3.16–3.9)</td>
    <td>0.380</td>
   </tr>
   <tr>
    <td/>
    <td>CSF protein (med: IQR)</td>
    <td>0.2 (0.1–0.3)</td>
    <td>0.42 (0.28–0.49)</td>
    <td>0.5 (0.39–0. 7)</td>
    <td>0.362</td>
   </tr>
   <tr>
    <td/>
    <td>Lactate (mmol per litter) [med: IQR]</td>
    <td>2.09 (1.5–3)</td>
    <td>2.35 (1.9–7.5)</td>
    <td>2.45 (2.1–3.1)</td>
    <td>1.00</td>
   </tr>
   <tr>
    <td/>
    <td>Evidence of other pathogens
     <sup>a</sup> in CSF (%)
    </td>
    <td>13 (31.7)</td>
    <td>1 (10)</td>
    <td>3 (10.7)</td>
    <td>1.0</td>
   </tr>
   <tr>
    <td rowspan="4">Co-infection
     <sup>a</sup>
    </td>
    <td>JEV (n)</td>
    <td>9</td>
    <td>1</td>
    <td>0</td>
    <td rowspan="4">NA</td>
   </tr>
   <tr>
    <td>DENV (n)</td>
    <td>4</td>
    <td>0</td>
    <td>0</td>
   </tr>
   <tr>
    <td>
     <italic>Cytomegalovirus</italic> (n) [CMV]
    </td>
    <td>0</td>
    <td>0</td>
    <td>2</td>
   </tr>
   <tr>
    <td>
     <italic>Mycobacterium tuberculosis</italic> (n) [MTB]
    </td>
    <td>0</td>
    <td>0</td>
    <td>1</td>
   </tr>
   <tr>
    <td>Outcome</td>
    <td>Death (%)</td>
    <td>15 (36.6)</td>
    <td>0</td>
    <td>0</td>
    <td>NA</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>ND</italic> not determined, 
   <italic>NA</italic> not applicable
  </p>
  <p>Note: 
   <sup>a</sup>Co-infection included detection of human IgM (anti JEV and DENV) and viral DNA (CMV) in CSF, or bacterial growth (
   <italic>Mycobacterium tuberculosis</italic>) in CSF culture
  </p>
  <p>
   <sup>b</sup>Other discharge diagnoses included sepsis (
   <italic>n</italic> = 5), dengue haemorrhagic fever (
   <italic>n</italic> = 1), colitis (
   <italic>n</italic> = 1), diarrhea (
   <italic>n</italic> = 1) metabolic disease (
   <italic>n</italic> = 1), and hepatitis (
   <italic>n</italic> = 1)
  </p>
  <p>
   <sup>c</sup>Statistical comparison between children and adults with EV detection in CSF
  </p>
 </table-wrap-foot>
</table-wrap>
